411 Stock Overview
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Zhejiang Int'l Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.21 |
| 52 Week High | CN¥15.80 |
| 52 Week Low | CN¥8.32 |
| Beta | 0.56 |
| 1 Month Change | -5.29% |
| 3 Month Change | -3.22% |
| 1 Year Change | -12.81% |
| 3 Year Change | -15.68% |
| 5 Year Change | -9.51% |
| Change since IPO | 348.79% |
Recent News & Updates
Shareholder Returns
| 411 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.9% | -0.7% | -0.2% |
| 1Y | -12.8% | -15.9% | -17.8% |
Return vs Industry: 000411 exceeded the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 000411 exceeded the CN Market which returned -17.8% over the past year.
Price Volatility
| 411 volatility | |
|---|---|
| 411 Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 000411 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000411's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 2,781 | Yang Wang | www.intmedic.com |
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. The company was founded in 1950 and is based in Hangzhou, China.
Zhejiang Int'l Group Co.,Ltd. Fundamentals Summary
| 411 fundamental statistics | |
|---|---|
| Market cap | CN¥5.37b |
| Earnings (TTM) | CN¥417.49m |
| Revenue (TTM) | CN¥32.22b |
12.8x
P/E Ratio0.2x
P/S RatioIs 411 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 411 income statement (TTM) | |
|---|---|
| Revenue | CN¥32.22b |
| Cost of Revenue | CN¥30.14b |
| Gross Profit | CN¥2.08b |
| Other Expenses | CN¥1.66b |
| Earnings | CN¥417.49m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 20, 2024
| Earnings per share (EPS) | 0.80 |
| Gross Margin | 6.46% |
| Net Profit Margin | 1.30% |
| Debt/Equity Ratio | 82.9% |
How did 411 perform over the long term?
See historical performance and comparison